QDPR Gene Hyperphenylalaninemia BH4 deficient type C Genetic Test
Introduction
The QDPR gene is associated with a condition called Hyperphenylalaninemia, BH4 deficient, type C. This condition is characterized by a deficiency in tetrahydrobiopterin (BH4), a cofactor required for the activity of the enzyme phenylalanine hydroxylase (PAH). PAH is responsible for converting the amino acid phenylalanine to another amino acid called tyrosine.
Test Details
A genetic test using Next-Generation Sequencing (NGS) technology can be performed to analyze the QDPR gene for any potential pathogenic variants or mutations. This test involves sequencing the entire coding region of the QDPR gene to identify any changes in the DNA sequence that may disrupt the normal function of the gene.
Components and Price
Test Name: QDPR Gene Hyperphenylalaninemia BH4 deficient type C Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
Report Delivery Time: 3 to 4 Weeks
Method
NGS Technology
Test Type
Metabolic Disorders
Doctor
General Physician
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for QDPR Gene Hyperphenylalaninemia, BH4 deficient, type C NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperphenylalaninemia, BH4 deficient, type C
Treatment
Identifying pathogenic variants in the QDPR gene can help confirm a diagnosis of Hyperphenylalaninemia, BH4 deficient, type C and guide appropriate treatment options. Treatment typically involves dietary restrictions to manage phenylalanine levels and supplementation with BH4 or other cofactors to support PAH activity.
Test Name | QDPR Gene Hyperphenylalaninemia BH4 deficient type C Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for QDPR Gene Hyperphenylalaninemia, BH4 deficient, type C NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperphenylalaninemia, BH4 deficient, type C |
Test Details |
The QDPR gene is associated with a condition called Hyperphenylalaninemia, BH4 deficient, type C. This condition is characterized by a deficiency in tetrahydrobiopterin (BH4), a cofactor required for the activity of the enzyme phenylalanine hydroxylase (PAH). PAH is responsible for converting the amino acid phenylalanine to another amino acid called tyrosine. A genetic test using Next-Generation Sequencing (NGS) technology can be performed to analyze the QDPR gene for any potential pathogenic variants or mutations. This test involves sequencing the entire coding region of the QDPR gene to identify any changes in the DNA sequence that may disrupt the normal function of the gene. Identifying pathogenic variants in the QDPR gene can help confirm a diagnosis of Hyperphenylalaninemia, BH4 deficient, type C and guide appropriate treatment options. Treatment typically involves dietary restrictions to manage phenylalanine levels and supplementation with BH4 or other cofactors to support PAH activity. |